Researchers from Stanford have developed a wearable sensor to monitor the size of tumors, which could assist new cancer drug evaluations.
Researchers create a blood test to predict a patient's risk for surgical site complications, such as infection.
Two Stanford Biodesign researchers designed a birth control app and case that helps women track their weekly doses.
Wearing caps labeled with names and roles made it easier for everyone in the operating room to communicate during C-sections, a Stanford study found.
A host of new technology at Stanford Hospital has earned the Healthcare and Life Sciences Eye on Innovation Award from Gartner, a research and advisory firm.
Through the Open COVID Pledge, industry leaders and companies are sharing their intellectual property and technologies to battle COVID-19.
A smartphone add-on, devised by an emergency medicine physician now at Stanford, detected a drunken stagger, through side-to-side sway, with 90% accuracy.
After treating a patient with an unusual ammonia metabolism problem, a Stanford researcher assembled a team to reimagine ammonia blood testing.
Stanford University bioengineers are developing a faster-acting formulation of insulin that can help diabetes patients better regulate their blood sugar levels.
A NOVA special featured Rhiju Das and the OpenVaccine project, in which gamers help scientists find an RNA molecule configuration for a COVID-19 vaccine.
Stanford researchers are devising new ways to tackle cancer through better, more sophisticated diagnostics and treatments.
Stanford psychologist Douglas Rait helps groups of Stanford Biodesign Innovation fellows hone their ability to work as a team, fueling their projects.
Researchers, working with those who are visually impaired, have developed a touch-based display that can produce physical, temporary models of objects.
A stress test helps researchers distinguish between different kinds of bacteria by testing their cell wall strength under pressure.
Zubin Damania, also known as ZDoggMD, presented at Stanford's 29th annual Jonathan J. King Lecture on the topic of connecting with patients.
The latest type 1 diabetes technology improves the stability of patients' blood sugar levels throughout the day and during sleep, according to a new trial.
